Answers are grounded in this paper and cite their sources.
Ustilaginoidin A has been formulated as 2, 2'-dimethyl-5, 5', 6, 6', 8, 8'-hexahydroxy-9, 9'-bis (4H-naphtho [2, 3-b] pyran-4-one) on the basis of the infrared and nuclear magnetic resonance spectral analyses of ustilaginoidin A and its degradation products, product A and product B and their derivatives.
No takes yet. Share an insight, caveat, or question.
Shibata et al. (1963) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: